menu-iconFind productsmenu-iconMy.Novozymes

The time for
biosolutions
is now

  

A new beginning to better our world with biology

Novozymes and Chr. Hansen have joined forces to create Novonesis, a leading biosolutions partner. Working closely with our customers, we’re transforming the way the world produces, consumes and lives.

Go to Novonesis.com

The combination of Novozymes and Chr. Hansen is now successfully completed

Read the announcement

Novonesis is a world-leading biosolutions partner for better business, healthier lives, and a healthier planet.

The era of biosolutions

Explore the era

It's time to overcome some of our greatest challenges with solutions rooted in biology. It’s time for the era of biosolutions.

Legacy Novozymes delivers solid last full-year results

Legacy Novozymes is delivering solid growth and earnings in a year characterized by changing market demands, with 6% organic sales growth in Q4 and 5% in 2023. This marks the last financial reporting from legacy Novozymes, and the new company, Novonesis, is already a reality.

Novonesis HQ in Lyngby, Denmark

Global challenges are queuing up. One key solution might be smaller than you think - microscopic even.  

Nevertheless, it holds the answer to solving multiple challenges at the same time. And there is so much left to discover. 

 

Why we should work together

Woman resting after exercising

Real-world problems solved...

Working closely with customers across more than 30 industries, we gain expert insights into real-world problems. With a co-creation mindset, we’re constantly translating those insights into relevant biosolutions. These solve problems across 140 countries and are often adapted to local conditions based on your local needs.

See how we solve problems
Enzymes

...with our unparalleled biotech toolbox...

Our thousands of experts draw on the enzymes, fermented proteins and microorganisms in our toolbox. In their search for insights-based biosolutions, they harness cutting-edge technologies such as gene-reading and handling, strain constructions and high-throughput screening.

Discover our unique toolbox
Deliver_at_scale

...and ability to produce and deliver at scale

The journey from your needs to our lab to global scale is a fast and efficient one, thanks to our unique fermentation, production and supply-chain capabilities. These span the globe, helping to ensure that we always deliver high-quality products to you at cost-effective, commercial scale.

Learn how we scale up

Latest articles

HMO news article
20.03.24 | 8 minute read

UC San Diego and Novonesis join forces to pioneer Human Milk Oligosaccharide research

Global leader in biosolutions partners with top-ranking university to create new research incubator.
HMO news article illustration
07.03.24 | 8 minute read

New Chinese review step achieved for Novonesis’ HMOs

All five single HMOs of Novonesis’ (previously Chr. Hansen) clinically documented 5 mix solution passed the biosafety review by the Chinese Ministry of Agriculture and Rural Affairs (MARA). 
Novonesis HQ in Lyngby, Denmark
01.02.24 | 8 minute read

Legacy Novozymes delivers solid last full-year results

Legacy Novozymes is delivering solid growth and earnings in a year characterized by changing market demands, with 6% organic sales growth in Q4 and 5% organic sales growth in 2023. This marks the last financial reporting from legacy Novozymes, and the new company, Novonesis, is already a reality.